◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2268

WuXi XDC Cayman Inc. (2268) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-08-11

WuXi XDC Cayman Inc. (2268) operates in the Diagnostics & Research industry and is headquartered in Wuxi, China with about 2,662 employees. Its market capitalization is roughly CNY 81 billion. In the fiscal year ended 2025-12-31, 2268 reported CNY 5.9B in revenue and CNY 1.5B in net income.

WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Interactive charts & full statements →

2268 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 5.9BCNY 4.1BCNY 2.1BCNY 990M
Gross ProfitCNY 2.1BCNY 1.2BCNY 560MCNY 261M
Operating Income (EBIT)CNY 1.7BCNY 948MCNY 402MCNY 142M
Net IncomeCNY 1.5BCNY 1.1BCNY 284MCNY 156M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2268 Free Cash Flow History

2268 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 14.4BCNY 9.1BCNY 6.7BCNY 2.5B
Total LiabilitiesCNY 3.7BCNY 2.5BCNY 1.3BCNY 1.0B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2268 viewer.

Other Companies in Diagnostics & Research

← 2267All “0-9” companies2269 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.